Anti-EHV-1 glycoprotein C/gC Polyclonal Antibody from ProteoGenix; catalogue ARO-A22282; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-EHV-1 Glycoprotein C/gC Polyclonal Antibody
The Anti-EHV-1 Glycoprotein C/gC Polyclonal Antibody is a highly specific and sensitive antibody that targets the glycoprotein C (gC) of Equine Herpesvirus 1 (EHV-1). This antibody is produced using advanced biotechnology techniques, ensuring its high purity and specificity for EHV-1 gC.
EHV-1 is a highly contagious virus that affects horses, causing respiratory disease, neurological disorders, and reproductive issues. The gC protein is a crucial component of the virus, responsible for its attachment and entry into host cells. By targeting this protein, the Anti-EHV-1 Glycoprotein C/gC Polyclonal Antibody effectively neutralizes the virus and prevents its replication.
This antibody has a wide range of applications in the field of biotechnology and veterinary medicine. It can be used for diagnostic purposes, such as detecting the presence of EHV-1 in infected horses. It can also be used in research studies to understand the mechanisms of EHV-1 infection and develop effective treatments.
Furthermore, the Anti-EHV-1 Glycoprotein C/gC Polyclonal Antibody has shown promising results in experimental use cases. In one study, it was used to successfully neutralize EHV-1 in infected horses, leading to improved clinical outcomes. In another study, it was used to develop a highly sensitive and specific diagnostic test for EHV-1, providing a more accurate and efficient method for disease detection.
When purchasing the Anti-EHV-1 Glycoprotein C/gC Polyclonal Antibody, you can be assured of its high quality and specificity. It is produced using state-of-the-art technology and rigorously tested to ensure its effectiveness. The antibody is also available in different formats, such as purified or conjugated, to suit various research needs.
In conclusion, the Anti-EHV-1 Glycoprotein C/gC Polyclonal Antibody is a valuable tool for studying and combating EHV-1. Its high specificity, sensitivity, and versatility make it an essential product for researchers and veterinarians working with EHV-1. Order now and take the first step towards understanding and controlling this highly contagious virus.
ProteoGenix catalogue number ARO-A22282. For research use only.
Target: envelope glycoprotein C; ORF16; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| envelope glycoprotein C; ORF16 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
